These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37652123)

  • 21. Pharmacological Management of Pediatric Clostridioides difficile Infection: Clarifying the Controversies.
    DeVine MN; MacBrayne CE; Child J; Blackmer AB
    J Pediatr Health Care; 2022; 36(2):181-192. PubMed ID: 34412953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Atypical Case of Monomicrobial
    Wang L; Li D; Chen Z; He L; Wang X; Tao L
    Front Cell Infect Microbiol; 2022; 12():853252. PubMed ID: 35433499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent development of small-molecular inhibitors against Clostridioides difficile infection.
    Chen J; Lu Y; Du Y; Wang H; Wu Q
    Bioorg Chem; 2022 Aug; 125():105843. PubMed ID: 35561529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics for primary prevention of
    Fajnzylber J; Patterson W; Deshpande A
    Curr Med Res Opin; 2023 Jun; 39(6):889-891. PubMed ID: 37078551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).
    Wolf J; Kalocsai K; Fortuny C; Lazar S; Bosis S; Korczowski B; Petit A; Bradford D; Croos-Dabrera R; Incera E; Melis J; van Maanen R
    Clin Infect Dis; 2020 Dec; 71(10):2581-2588. PubMed ID: 31773143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prosthesis joint infection due to Clostridioides difficile and literature review].
    Astor Molero S; Vázquez-Temprano N; Camacho Zamora P; Sola Mallo X; Álvarez García P; Rodríguez García JC
    Rev Esp Quimioter; 2023 Dec; 36(6):638-640. PubMed ID: 37814780
    [No Abstract]   [Full Text] [Related]  

  • 29. Association between
    Evans ME; McCauley BP; Simbartl LA
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1940-1941. PubMed ID: 34325761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Clostridium innocuum Masquerade as Clostridioides difficile?
    Skinner AM; Petrella L; Spandoni S; Serna-Perez F; Johnson S
    Clin Infect Dis; 2022 Sep; 75(7):1268-1269. PubMed ID: 35579505
    [No Abstract]   [Full Text] [Related]  

  • 31. Update on Clostridioides difficile Infection in Older Adults.
    Donskey CJ
    Infect Dis Clin North Am; 2023 Mar; 37(1):87-102. PubMed ID: 36805016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining the decision problem: a scoping review of economic evaluations for Clostridioides difficile interventions.
    Richardson M; Erman A; Daneman N; Miller FA; Sander B
    J Hosp Infect; 2022 Mar; 121():22-31. PubMed ID: 34813872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community-onset Clostridioides difficile infection in a pregnant woman without traditional risk factors.
    Tsai WC; Tsai PJ; Tsai BY; Tsai CS; Chen PL; Lee NY; Ko WC; Syue LS
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1188-1189. PubMed ID: 34099421
    [No Abstract]   [Full Text] [Related]  

  • 34. Fidaxomicin for the treatment of
    Skinner AM; Scardina T; Kociolek LK
    Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant Clostridioides difficile and Edwardsiella tarda Infection in a Patient with Ulcerative Colitis.
    Fukuda H; Shinzaki S; Doi A; Yoshii S; Yoshioka T; Tsujii Y; Inoue T; Sakamori R; Takehara T
    Intern Med; 2023 Jun; 62(12):1757-1763. PubMed ID: 36288985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clostridioides difficile Near-Patient Testing Versus Centralized Testing: A Pragmatic Cluster Randomized Crossover Trial.
    Doolan CP; Sahragard B; Leal J; Sharma A; Kim J; Spackman E; Hollis A; Pillai DR
    Clin Infect Dis; 2023 Jun; 76(11):1911-1918. PubMed ID: 36718646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alanyl-glutamine supplementation for
    Warren CA; Shin JH; Bansal EN; Costa DVDS; Wang XQ; Wu M; Swann JR; Behm BW; Targonski PV; Archbald-Pannone L
    BMJ Open; 2023 Jul; 13(7):e075721. PubMed ID: 37474181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a novel Clostridioides difficile-selective growth broth under aerobic conditions.
    Ito Y; Kaneko N; Yoshida M; Nakayama H
    Diagn Microbiol Infect Dis; 2023 Oct; 107(2):116020. PubMed ID: 37536259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridioides difficile Infection in Children: Research Progress, Pitfalls, and Priorities.
    Kociolek LK; Burnham CD; Nicholson MR; Zackular JP
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S1-S2. PubMed ID: 34791394
    [No Abstract]   [Full Text] [Related]  

  • 40. Clostridioides difficile infection in Africa: A narrative review.
    Kullin B; Abratt VR; Reid SJ; Riley TV
    Anaerobe; 2022 Apr; 74():102549. PubMed ID: 35337974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.